Vofatamab (B-701)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vofatamab (B-701), covering 2020-02-17 to 2020-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma [Phase 1, Phase 2]